Total Payments
$4,745
2024 Payments
$1,874
Companies
13
Transactions
176
Medicare Patients
420
Medicare Billing
$74,341
Payment Breakdown by Category
Food & Beverage$4,586 (96.7%)
Education$158.40 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,586 | 174 | 96.7% |
| Education | $158.40 | 2 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,006 | 37 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $765.04 | 16 | $0 (2024) |
| Alkermes, Inc. | $703.89 | 33 | $0 (2024) |
| Lundbeck LLC | $623.28 | 24 | $0 (2024) |
| ITI, Inc. | $490.50 | 14 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $461.86 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $286.05 | 15 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $141.36 | 7 | $0 (2020) |
| ABBVIE INC. | $122.05 | 6 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $90.38 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,874 | 76 | Teva Pharmaceuticals USA, Inc. ($698.32) |
| 2023 | $1,221 | 38 | ITI, Inc. ($323.96) |
| 2022 | $557.37 | 12 | Neurocrine Biosciences, Inc. ($238.25) |
| 2021 | $508.51 | 25 | ITI, Inc. ($166.54) |
| 2020 | $193.00 | 10 | Sunovion Pharmaceuticals Inc. ($108.91) |
| 2019 | $376.73 | 14 | Neurocrine Biosciences, Inc. ($122.54) |
| 2018 | $13.95 | 1 | Otsuka America Pharmaceutical, Inc. ($13.95) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $32.21 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.94 | General |
| Category: Central Nervous System | ||||||
| 11/18/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $30.96 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: CNS | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: Neurology | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $12.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Central Nervous System | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $21.44 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Central Nervous System | ||||||
| 09/30/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $26.19 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: Central Nervous System | ||||||
| 09/24/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: CNS | ||||||
| 09/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $33.65 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Neurology | ||||||
| 09/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Neurology | ||||||
| 08/27/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $29.10 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 92 | 392 | $77,328 | $15,685 |
| 2022 | 4 | 101 | 441 | $79,079 | $17,824 |
| 2021 | 3 | 114 | 534 | $74,450 | $24,923 |
| 2020 | 3 | 113 | 457 | $51,645 | $15,908 |
Total Patients
420
Total Services
1,824
Medicare Billing
$74,341
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 116 | $17,437 | $5,777 | 33.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 35 | 186 | $50,034 | $4,622 | 9.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 16 | 68 | $4,793 | $3,595 | 75.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 22 | $5,063 | $1,691 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 31 | 131 | $19,692 | $6,230 | 31.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 22 | 117 | $8,247 | $6,037 | 73.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 37 | 173 | $46,537 | $3,908 | 8.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 20 | $4,603 | $1,649 | 35.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 38 | 287 | $20,231 | $15,475 | 76.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 36 | 103 | $15,483 | $5,703 | 36.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 40 | 144 | $38,736 | $3,745 | 9.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 52 | 337 | $23,755 | $13,912 | 58.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 26 | 46 | $7,984 | $1,134 | 14.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 35 | 74 | $19,906 | $863.12 | 4.3% |
About Dr. Roxana Llovet, MD
Dr. Roxana Llovet, MD is a Psychiatry healthcare provider based in Bridgeport, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639250087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roxana Llovet, MD has received a total of $4,745 in payments from pharmaceutical and medical device companies, with $1,874 received in 2024. These payments were reported across 176 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($4,586).
As a Medicare-enrolled provider, Llovet has provided services to 420 Medicare beneficiaries, totaling 1,824 services with total Medicare billing of $74,341. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Bridgeport, CT
- Active Since 10/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1639250087
Products in Payments
- CAPLYTA (Drug) $952.36
- INGREZZA (Drug) $765.04
- UZEDY (Drug) $542.36
- ABILIFY MAINTENA (Drug) $503.48
- ARISTADA (Drug) $496.46
- ABILIFY ASIMTUFII (Drug) $382.28
- Austedo XR (Drug) $352.20
- LYBALVI (Drug) $190.62
- LATUDA (Drug) $141.36
- VRAYLAR (Drug) $140.49
- Fanapt (Drug) $70.97
- REXULTI (Drug) $23.57
- COBENFY (Drug) $21.44
- HETLIOZ (Drug) $19.41
- VIVITROL (Drug) $16.81
- SPRAVATO (Drug) $14.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Bridgeport
Simon Mcclure, Md, MD
Psychiatry — Payments: $23,653
Psychiatry $23,653
Dr. Jisha Philip, M.d, M.D
Psychiatry — Payments: $3,494
Psychiatry $3,494
Tasneem Khan, Md, MD
Psychiatry — Payments: $1,886
Psychiatry $1,886
Muhammad Salman, M.d, M.D
Psychiatry — Payments: $1,656
Psychiatry $1,656
Mr. Jose Camacho-Pantoja, M.d, M.D
Psychiatry — Payments: $1,223
Psychiatry $1,223
David Gianetti, M.d, M.D
Psychiatry — Payments: $967.94
Psychiatry $967.94